Trial Profile
A cross-sectional trial to assess chronic use of tocilizumab in patients with rheumatoid arthritis and the relationship with clinical response
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics; Therapeutic Use
- 25 Jul 2015 New trial record
- 10 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.